Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
11.08. | FDA restricts use of bluebird's Skysona gene therapy | ||
11.08. | Boehringer back in cancer with Hernexeos approval | ||
11.08. | Vinay Prasad returns to FDA | ||
08.08. | Iovance cuts staff on slower cell therapy sales growth | ||
08.08. | GSK and CureVac settle mRNA patent spat with Pfizer/BioNTech | ||
08.08. | Click, Boehringer DTx for schizophrenia passes phase 3 test | ||
07.08. | Strand raises $153m for RNA meds, and other bio financings | ||
07.08. | FDA makes it easier to set up US manufacturing sites | ||
07.08. | England poised to roll out drug for rare eye disease LHON | ||
07.08. | Lilly weakens on oral weight-loss drug data | ||
07.08. | Pushback against Kennedy's mRNA decision builds | ||
07.08. | Jazz gets FDA okay for Chimerix brain cancer drug | ||
07.08. | Rumour mill says Novartis may want to buy Avidity | ||
06.08. | Bayer's job cull nears 12,000, with more to come | ||
06.08. | Meta harvested health data to target ads, jury concludes | ||
06.08. | Novo Nordisk weakens again on interim results readout | ||
06.08. | New medicines review process under NHS 10-year plan emerges | ||
06.08. | RFK Jr cancels $500m in funding for mRNA vaccines | ||
05.08. | Vertex is smarting from a pain portfolio setback | ||
05.08. | Noom expands its GLP-1 range with 'microdose' package | ||
05.08. | Gates Foundation puts $2.5bn into 'ignored' women's health | ||
05.08. | NICE calls for better care after weight-loss therapy ends | ||
05.08. | Gedeon Richter brings HRT option back to the UK market | ||
04.08. | Top medical groups barred from CDC vaccine workgroups | ||
04.08. | UK starts 'world-first' gonorrhoea vaccination push |